Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer

Neoantigens are optimal tumor-specific targets for T-cell based immunotherapy, especially for patients with “undruggable” mutated driver genes. T-cell immunotherapy can be a “universal” treatment for HLA genotype patients sharing same oncogenic mutations. To identify potential neoantigens for therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jie, Zhao, Wenyi, Wu, Jingcheng, Lu, Jun, Ding, Yongfeng, Wu, Shanshan, Wang, Haiyong, Ding, Ding, Mo, Fan, Zhou, Zhan, Teng, Lisong, Chen, Shuqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595338/
https://www.ncbi.nlm.nih.gov/pubmed/31312661
http://dx.doi.org/10.1155/2019/8103142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595338/
https://www.ncbi.nlm.nih.gov/pubmed/31312661
http://dx.doi.org/10.1155/2019/8103142

Ejemplares similares